GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vascular Solutions Inc (NAS:VASC) » Definitions » Shiller PE Ratio

Vascular Solutions (Vascular Solutions) Shiller PE Ratio : 84.85 (As of Apr. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Vascular Solutions Shiller PE Ratio?

As of today (2024-04-26), Vascular Solutions's current share price is $56.00. Vascular Solutions's E10 for the quarter that ended in Sep. 2016 was $0.66. Vascular Solutions's Shiller PE Ratio for today is 84.85.

The historical rank and industry rank for Vascular Solutions's Shiller PE Ratio or its related term are showing as below:

VASC's Shiller PE Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.11
* Ranked among companies with meaningful Shiller PE Ratio only.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vascular Solutions's adjusted earnings per share data for the three months ended in Sep. 2016 was $0.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.66 for the trailing ten years ended in Sep. 2016.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vascular Solutions Shiller PE Ratio Historical Data

The historical data trend for Vascular Solutions's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vascular Solutions Shiller PE Ratio Chart

Vascular Solutions Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 504.12 64.98 54.90 50.58 59.84

Vascular Solutions Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.13 59.84 55.45 66.23 72.71

Competitive Comparison of Vascular Solutions's Shiller PE Ratio

For the Medical Devices subindustry, Vascular Solutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vascular Solutions's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vascular Solutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vascular Solutions's Shiller PE Ratio falls into.



Vascular Solutions Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vascular Solutions's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=56.00/0.66
=84.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vascular Solutions's E10 for the quarter that ended in Sep. 2016 is calculated as:

For example, Vascular Solutions's adjusted earnings per share data for the three months ended in Sep. 2016 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2016 (Change)*Current CPI (Sep. 2016)
=0.31/101.8610*101.8610
=0.310

Current CPI (Sep. 2016) = 101.8610.

Vascular Solutions Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200612 0.010 85.142 0.012
200703 -0.370 86.640 -0.435
200706 0.040 87.906 0.046
200709 0.000 87.964 0.000
200712 0.040 88.616 0.046
200803 0.010 90.090 0.011
200806 -0.030 92.320 -0.033
200809 0.110 92.307 0.121
200812 0.920 88.697 1.057
200903 0.060 89.744 0.068
200906 0.090 91.003 0.101
200909 0.090 91.120 0.101
200912 0.100 91.111 0.112
201003 0.210 91.821 0.233
201006 0.090 91.962 0.100
201009 0.090 92.162 0.099
201012 0.880 92.474 0.969
201103 0.100 94.283 0.108
201106 0.130 95.235 0.139
201109 0.220 95.727 0.234
201112 0.130 95.213 0.139
201203 0.120 96.783 0.126
201206 0.150 96.819 0.158
201209 0.160 97.633 0.167
201212 0.180 96.871 0.189
201303 0.130 98.209 0.135
201306 0.170 98.518 0.176
201309 0.160 98.790 0.165
201312 0.200 98.326 0.207
201403 0.160 99.695 0.163
201406 0.180 100.560 0.182
201409 0.150 100.428 0.152
201412 0.230 99.070 0.236
201503 0.120 99.621 0.123
201506 0.210 100.684 0.212
201509 0.160 100.392 0.162
201512 0.090 99.792 0.092
201603 -0.010 100.470 -0.010
201606 0.310 101.688 0.311
201609 0.310 101.861 0.310

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vascular Solutions  (NAS:VASC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vascular Solutions Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Vascular Solutions's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vascular Solutions (Vascular Solutions) Business Description

Traded in Other Exchanges
N/A
Address
Vascular Solutions Inc was incorporated in the state of Minnesota in December 1996. It is a medical device company, creates new minimally invasive medical devices, and delivers these products and related services to physicians through its direct domestic sales force and its international distribution network. The Company's products and services are divided into three categories: Catheter products; Hemostat products and Vein products and services. Catheter products consist principally of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the GuideLiner catheter used to access discrete regions of the coronary anatomy and the Pronto extraction catheters used in treating acute myocardial infarction. Hemostat products consist principally of blood clotting products, such as the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets. Vein products and services consist principally of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The Company manufactures its products in its facilities located in the suburbs of Minneapolis, Minnesota and in the country of Ireland. The catheter manufacturing and packaging processes occur under a controlled clean room environment. It purchases components from various suppliers and rely on single sources for several parts of its products. It purchases its requirements for thrombin for use in manufacturing products sold in the U.S. under the Thrombin-JMI Supply Agreement with King. Its main competitors include: Medtronic, Boston Scientific, Covidien, Merit Medical, Marine Polymer Technologies, Cook Medical, Spectranetics, AngioDynamics and Terumo. The Company's products and services are regulated in the United States as medical devices by the FDA under the Federal Food, Drug and Cosmetic Act.
Executives
John L Erb director C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT N., MINNEAPOLIS, MN 55369
Richard Nigon director CEDAR POINT CAPITAL, 150 SOUTH 5TH STREET, MINNEAPOLIS MN 55402
Richard W Kramp director 174 STONEBRIDGE ROAD, ST. PAUL MN 55118
Stephens Group Inc 10 percent owner 111 CENTER ST, STE 2300, LITTLE ROCK AR 72201
Paulson J Robert Jr director
Gregg S Sutton officer: VP R&D 6464 SYCAMORE COURT NORTH, MINNEAPOLIS MN 55369
Michael Nagel officer: VP of Sales C/O VASCULAR SOLUTIONS INC, 6464 SYCAMORE COURT NORTH, MINNEAPOLIS MN 55369
Steve Patterson 10 percent owner 111 CENTER STREET STE 2300, LITTLE ROCK AR 72201

Vascular Solutions (Vascular Solutions) Headlines

From GuruFocus

Mairs & Power Comments on Vascular Solutions

By Holly LaFon Holly LaFon 12-01-2015

Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-04-2010

Mario Gabelli Comments on Vascular Solutions

By Holly LaFon Holly LaFon 01-31-2017